Price $103.08 |
Market Cap
172.13B
|
Sector Health Care |
Div. Growth
13.60%
|
|
P/E
20.1
|
P/B
4.65
|
P/S
3.73
|
Dividend %
1.90%
|
|
P/CF
617.3
|
P/FCF
33.0
|
Op. Cash Flow
10.24M
|
FCF
2.9
|
|
Op. Margin
22.40%
|
Net Margin
18.80%
|
ROE
24.10%
|
ROI
13.50%
|
|
ROA
11.50%
|
EPS Growth
35.00%
|
Current Ratio
1.8
|
Debt/Equity
48.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| InfuSystem Holdings Inc (INFU) | $7.12 | - | - | 145.7M | Strong Buy |
| Eton Pharmaceuticals Inc (ETON) | $2.21 | - | - | 53.6M | Strong Buy |
| NightHawk Biosciences Inc (NHWK) | $1.85 | - | - | 46.4M | Strong Buy |
| Novo Integrated Sciences Inc (NVOS) | $1.12 | - | - | 34.7M | Strong Buy |
| Elanco Animal Health Inc (ELAN) | $12.87 | - | - | 6B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
